Akers biosciences伦敦证券交易所
Akers Biosciences Aktie im Überblick: Realtimekurs, Chart, Fundamentaldaten, sowie aktuelle Nachrichten und Meinungen. Products – Akers Biosciences, Inc. Akers Bio develops, manufactures, and supplies rapid, point-of-care screening and testing products designed to bring health-related information directly to the patient or clinician in a timely and cost-efficient manner. All of Akers Bio’s rapid, single-use tests are performed in … 14 May 2020 Akers Biosciences Announces $4.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules. 14 May 2020 Akers Biosciences and Premas Biotech Announce Successful Completion of Vaccine Prototype & Obtained First Images of VLP Find the latest Akers Biosciences Inc. (AKER) stock quote, history, news and other vital information to help you with your stock trading and investing.
美国股市收低；截至收盘道琼斯工业平均指数下跌1.02% 提供者 …
伦敦证券交易所（英语：London Stock Exchange，缩写：LSE，简称“伦敦证交所”）是 世界四大证券交易所之一。官方网站网址: http://www.londonstockexchange.com/ Котировки акции Akers Biosciences. NASDAQ. 3.59. -2.45%. USD. LAST на 05.06.2020. BID 3.57. ASK 3.64. Сегодня; 1 мес; 3 мес; 6 мес; 1 год; 3 года
美国股市上涨；截至收盘道琼斯工业平均指数上涨0.10% – 淘股吧
Contact our support team if you have any enquiries about any of our products. Call: (856) 848-8698. Email: info@akersbio.com Akers Biosciences (AKER) reports earnings on 8/14/2020. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings. Akers Biosciences Inc. annual stock financials by MarketWatch. View the latest AKER financial statements, income statements and financial ratios. * AKERS BIOSCIENCES INC FILES FOR OFFER OF UP TO 793,437 SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDERS - SEC FILING Source text: (https://bit.ly/2ZstE7n) Further company coverage: BRIEF-Akers Akers Biosciences, Inc. (the “Company”) (AKER), a developer of rapid health information technologies, today announced that Premas Biotech, its partner in the development of a vaccine candidate
Akers Biosciences, Inc., together with its subsidiaries, develops, manufactures, and supplies rapid screening and testing products designed to deliver healthcare information to healthcare providers and consumers in the United States, the People's Republic of China, and internationally.
Akers Biosciences Inc. annual stock financials by MarketWatch. View the latest AKER financial statements, income statements and financial ratios. * AKERS BIOSCIENCES INC FILES FOR OFFER OF UP TO 793,437 SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDERS - SEC FILING Source text: (https://bit.ly/2ZstE7n) Further company coverage: BRIEF-Akers Akers Biosciences, Inc. (the “Company”) (AKER), a developer of rapid health information technologies, today announced that Premas Biotech, its partner in the development of a vaccine candidate 纽约证券交易所2056只个股下跌，数量上超过收高个股数——784，同时85只股票未涨未跌，基本持平；纳斯达克股票交易所1870只个股收跌，794只股票上涨，此外69只个股基本没变。 阿帕奇公司(Apache) (NYSE:APA)股票大跌至低点，下跌12.30%（2.74点），收于19.54。 BD Biosciences provides flow cytometers, reagents, tools, and a wide range of services to support the work of researchers and clinicians who understand disease and improve care.
t.eastmoney.com
Company Overview Akers Biosciences mission is dedicated to solving global health challenges. Akers was founded in 1989 and has over 30 years of success in the health diagnostic industry having developed proprietary, in vitro diagnostic technologies.